Testing MK-7262 and Enlicitide for High Lipoprotein(a)
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests two experimental drugs designed to lower lipoprotein(a)—a type of cholesterol particle linked to heart disease—in people whose levels remain high despite taking statins (cholesterol-lowering medications). The goal is to see if these drugs can safely reduce this risk factor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your lipoprotein(a) level must be 150 nmol/L or higher
- You must be taking a stable, optimized dose of statin medication for at least 30 days with no planned changes
- You cannot have a genetic form of high cholesterol (familial hypercholesterolemia)
- You cannot have serious heart conditions, recent heart attacks, strokes, or severe heart rhythm problems
- You cannot have uncontrolled HIV, active hepatitis B or C, severe kidney disease, or uncontrolled diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medicine called lepodisiran can shrink plaque in heart arteries for adults with high Lp(a) (a type of cholesterol linked to heart disease) who have had a heart event or are at serious risk. The trial uses CT scans to monitor changes in your arteries.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
This study tests an oral medicine (HRS-5346) to lower lipoprotein(a), a type of fat in the blood linked to heart problems. It might help people with high levels who are at increased risk for heart attacks or strokes.
This trial tests whether a new once-daily pill called SAL0137 can safely lower Lp(a), a type of cholesterol that raises heart attack and stroke risk. It's for adults with high Lp(a) and other heart risk factors, like prior heart problems or diabetes.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.
Hear when a new Lipoprotein(a) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.